Correlation Between Catalyst Pharmaceuticals and Allient

Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Allient at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Allient into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Pharmaceuticals and Allient, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Allient and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Allient. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Allient.

Diversification Opportunities for Catalyst Pharmaceuticals and Allient

0.51

Correlation Coefficient

Catalyst Pharmaceuticals  Allient

Very weak diversification

The 3 months correlation between Catalyst and Allient is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Allient in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allient and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Allient. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allient has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Allient go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Allient

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 1.07 times more return on investment than Allient. However, Catalyst Pharmaceuticals is 1.07 times more volatile than Allient. It trades about 0.03 of its potential returns per unit of risk. Allient is currently generating about -0.01 per unit of risk. If you would invest  1,834  in Catalyst Pharmaceuticals on September 19, 2024 and sell it today you would earn a total of  331.00  from holding Catalyst Pharmaceuticals or generate 18.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Catalyst Pharmaceuticals  vs.  Allient

Catalyst Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Catalyst Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Allient

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Allient are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Allient unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Catalyst Pharmaceuticals and Allient

The main advantage of trading using opposite Catalyst Pharmaceuticals and Allient positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Allient can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allient will offset losses from the drop in Allient's long position.

The idea behind Catalyst Pharmaceuticals and Allient pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.